FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 39 filers reported holding FULCRUM THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 2.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,338,950 | +125.1% | 977,241 | +67.3% | 0.00% | – |
| Q2 2023 | $1,927,623 | +81.0% | 584,128 | +56.3% | 0.00% | – |
| Q1 2023 | $1,065,236 | -44.3% | 373,767 | +42.4% | 0.00% | – |
| Q4 2022 | $1,911,000 | -22.0% | 262,500 | -13.3% | 0.00% | -100.0% |
| Q3 2022 | $2,450,000 | +97.6% | 302,806 | +19.7% | 0.00% | – |
| Q2 2022 | $1,240,000 | -47.8% | 252,987 | +152.0% | 0.00% | – |
| Q1 2022 | $2,374,000 | +6.8% | 100,400 | -20.1% | 0.00% | – |
| Q4 2021 | $2,222,000 | +0.5% | 125,600 | +60.2% | 0.00% | – |
| Q3 2021 | $2,211,000 | +494.4% | 78,400 | +148.1% | 0.00% | – |
| Q1 2021 | $372,000 | +318.0% | 31,594 | +135.8% | 0.00% | – |
| Q3 2019 | $89,000 | – | 13,397 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |